Condition: Stroke Ischemic · Medium Vessel Occlusions · Sponsor: Beijing Tiantan Hospital
The investigators initiated a multicenter, prospective, randomized, open label, blinded-endpoint (PROBE) controlled trial to evaluate the efficacy and safety of perfusion-guided endovascular treatment (EVT) compared to standard medical care for patients with acute ischemic stroke due to medium vessel occlusion (MeVO) within 24 hours from symptom onset.
This description comes directly from the study's public registry record.
Yunyun Xiong, professor · 86-10-59978350 · xiongyunyun@bjtth.org
Always discuss trial participation with your own doctor first.
| Beijing tiantan hospital | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Daxing District People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Xingtang County People's Hospital | Longzhou, Hebei, China | Recruiting |
| Luoyang Yiluo Hospital | Luoyang, Henan, China | Recruiting |
| People's Hospital of Queshan | Panlong, Henan, China | Recruiting |
| Changle People's Hospital | Changle, Shandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07323368